Skip to main content

Table 2 Distribution of genotypes and serum levels of vascular endothelial growth factor

From: The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer

Genotype

Polymorphism

No. of patients

%

Mean ± SD (pg/ml)

P*

−2578C/A

CC

116

61.1

453.2 ± 278.8

0.606

 

CA

63

33.2

520.0 ± 392.3

 
 

AA

11

5.8

523.9 ± 391.7

 

−2489C/T

CC

116

61.1

453.2 ± 278.8

0.117

 

CT

60

31.6

478.4 ± 350.0

 
 

TT

14

7.4

724.0 ± 517.7

 

−1498 T/C

TT

116

61.1

453.2 ± 278.8

0.563

 

TC

61

32.1

512.2 ± 400.7

 
 

CC

13

6.8

568.2 ± 324.9

 

−634 G/C

GG

54

28.4

889.7 ± 453.7

0.004

 

GC

93

48.9

471.4 ± 222.6

 
 

CC

43

22.6

410.7 ± 222.6

 

+936C/T

CC

135

71.1

440.0 ± 292.0

0.722

 

CT

45

23.7

495.5 ± 329.3

 
 

TT

10

5.3

502.6 ± 371.1

 

+1612 G/A

GG

139

73.2

472.4 ± 339.2

0.371

 

GA

47

24.7

538.3 ± 295.9

 
 

AA

4

2.1

267.0 ± 159.3

 
  1. *by Mann–Whitney.
  2. SD: standard deviation.